Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chabannon C"'
Autor:
Lorentino F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy. lorentino.francesca@hsr.it., Labopin M; Hôpital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France.; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Paris, France., Ciceri F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy., Vago L; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.; Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy., Fleischhauer K; Institute for Experimental Cellular Therapy, Essen University Hospital, Essen, Germany.; German Cancer Consortium, Heidelberg, Germany., Afanasyev B; Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation, St. Petersburg, Russia., Kröger N; Department of Stem cell Transplantation, University Hospital Eppendorf, Hamburg, Germany., Cornelissen JJ; Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, Netherlands., Lovira M; Hospital Clinic Institute of Hematology & Oncology, Barcelona, Spain., Meijer E; Department of Hematology, University Medical Center, Amsterdam, Netherlands., Vitek A; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Elmaagacli A; Asklepios Klinik St. George, Lohmühlenstrasse, Hamburg, Germany., Blaise D; Programme de Transplantation & Thérapie Cellulaire - Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France., Ruggeri A; Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.; Cellular Therapy and Immunobiology Working Party (CTIWP), Marseille, France., Chabannon C; Cellular Therapy and Immunobiology Working Party (CTIWP), Marseille, France.; Centre d'Investigations Cliniques en Biothérapies, Institut Paoli Calmette Marseille, Marseille, France., Nagler A; Hôpital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France., Mohty M; Hôpital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France.; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Paris, France.
Publikováno v:
Leukemia [Leukemia] 2021 Feb; Vol. 35 (2), pp. 585-594. Date of Electronic Publication: 2020 May 14.
Autor:
Mohty M; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Sorbonne Université, INSERM UMRs 938, Paris, France. mohamad.mohty@inserm.fr., Gautier J; Clinical Research Division, Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Malard F; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Sorbonne Université, INSERM UMRs 938, Paris, France., Aljurf M; Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Bazarbachi A; Department of Internal Medicine/ American University of Beirut, Beirut, Lebanon., Chabannon C; Institut Paoli-Calmettes, Inserm CBT-1409 & Aix-Marseille Université, Marseille, France., Kharfan-Dabaja MA; Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Savani BN; Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, TN, USA., Huang H; Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Institute of Hematology, Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, 310058, China., Kenderian S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Nagler A; The Chaim Sheba Medical Center, Tel-Hashomer, Affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Publikováno v:
Leukemia [Leukemia] 2019 Dec; Vol. 33 (12), pp. 2767-2778. Date of Electronic Publication: 2019 Nov 05.
Autor:
Tiberi G; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Pekowska A; CIML, CNRS UMR6102, INSERM U631, Aix-Marseille Université, Marseille, France., Oudin C; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Ivey A; 1] Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK [2] GSTS Pathology, Guy's Hospital, London, UK., Autret A; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Prebet T; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Koubi M; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Lembo F; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Mozziconacci MJ; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Bidaut G; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Chabannon C; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Grimwade D; Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK., Vey N; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Spicuglia S; CIML, CNRS UMR6102, INSERM U631, Aix-Marseille Université, Marseille, France., Calmels B; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France., Duprez E; CRCM (Epigenetic Factors in Normal and Malignant Hematopoiesis), Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105; CNRS, UMR7258, Marseille, France.
Publikováno v:
Leukemia [Leukemia] 2015 May; Vol. 29 (5), pp. 1202-6. Date of Electronic Publication: 2014 Dec 08.
Autor:
Mohty M, de Lavallade H, El-Cheikh J, Ladaique P, Faucher C, Fürst S, Vey N, Coso D, Stoppa AM, Gastaut JA, Chabannon C, Blaise D
Publikováno v:
Leukemia [Leukemia] 2009 Jan; Vol. 23 (1), pp. 194-6. Date of Electronic Publication: 2008 Jun 26.
Autor:
Belaaloui G; Centre de Thérapie Cellulaire et Génique, Institut Paoli-Calmettes, Centre Régional de Lutte Contre le Cancer Provence-Alpes-Côte d'Azur, 232 boulevard Sainte-Marguerite, 13273 Marseille Cedex 9, France., Imbert AM, Bardin F, Tonnelle C, Dubreuil P, Lopez M, Chabannon C
Publikováno v:
Leukemia [Leukemia] 2003 Jun; Vol. 17 (6), pp. 1137-45.
Autor:
Chabannon C, Le Corroller AG, Viret F, Eillen C, Faucher C, Moatti JP, Viens P, Vey N, Braud AC, Novakovitch G, Ladaique P, Stoppa AM, Camerlo J, Genre D, Maraninchi D, Blaise D
Publikováno v:
Leukemia [Leukemia] 2003 Apr; Vol. 17 (4), pp. 811-3.
Autor:
Mohty M; Unité de Transplantation et de Thérapie Cellulaire (UTTC), Institut Paoli-Calmettes, Marseille, France., Faucher C, Vey N, Chabannon C, Sainty D, Arnoulet C, Gaugler B, Gastaut JA, Maraninchi D, Olive D, Blaise D
Publikováno v:
Leukemia [Leukemia] 2002 Oct; Vol. 16 (10), pp. 2129-33.
Autor:
Bouabdallah R; Department of Hematology, Institut J Paoli-I Calmettes, Regional Cancer Center-Université de la Méditerranée, Marseille, France., Stoppa AM, Rossi JF, Lepeu G, Coso D, Xerri L, Ladaique P, Chabannon C, Blaise D, Bardou VJ, Alzieu C, Gastaut JA, Maraninchi D
Publikováno v:
Leukemia [Leukemia] 1999 Jun; Vol. 13 (6), pp. 950-6.
Autor:
Humeau L; Laboratoire de Biologie Cellulaire and Centre de Thérapie Génique, Institut Paoli-Calmettes, Centre Régional de Lutte Contre le Cancer Provence-Alpes-Côte d'Azur, Marseille, France., Namikawa R, Bardin F, Mannoni P, Roncarolo MG, Chabannon C
Publikováno v:
Leukemia [Leukemia] 1999 Mar; Vol. 13 (3), pp. 438-52.